{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T01:07:35Z","timestamp":1773018455685,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.annder.2021.06.003","type":"journal-article","created":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T08:45:10Z","timestamp":1625215510000},"page":"92-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Male genital vitiligo"],"prefix":"10.1016","volume":"149","author":[{"given":"J.-N.","family":"Dauendorffer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Skayem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Passeron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2021.06.003_bib0245","first-page":"145","article-title":"Incidence of male genital vitiligo","volume":"57","author":"Moss","year":"1981","journal-title":"Br J Vener Dis"},{"key":"10.1016\/j.annder.2021.06.003_bib0250","first-page":"492","article-title":"Depigmentation of the male genitalia","volume":"34","author":"Gaffoor","year":"1984","journal-title":"Cutis"},{"key":"10.1016\/j.annder.2021.06.003_bib0255","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jaad.2019.02.008","article-title":"Cross-cultural validation of a short-form of the Vitiligo Impact Patient scale (VIPs)","volume":"81","author":"Ezzedine","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2021.06.003_bib0260","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/jdv.12171","article-title":"Distribution patterns in generalized vitiligo","volume":"28","author":"Speeckaert","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2021.06.003_bib0265","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/bjd.12034","article-title":"Clinical features and histological findings are potential indicators of activity in lesions of common vitiligo","volume":"168","author":"Benzekri","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2021.06.003_bib0270","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/pcmr.12065","article-title":"Development and validation of the K-VSCOR for scoring Koebner's phenomenon in vitiligo\/non-segmental vitiligo","volume":"26","author":"Diallo","year":"2013","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.annder.2021.06.003_bib0275","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1755-148X.2011.00838.x","article-title":"Koebner's phenomenon in vitiligo: European position paper","volume":"24","author":"van Geel","year":"2011","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.annder.2021.06.003_bib0280","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/ced.14151","article-title":"Genital vitiligo with reticular pigmentation in a male patient","volume":"45","author":"Vaccari","year":"2019","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.annder.2021.06.003_bib0285","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/bjd.12006","article-title":"Localized depigmentation on genital melanosis: a clue for the understanding of vitiligo","volume":"168","author":"Harmelin","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2021.06.003_bib0290","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jaad.2015.05.014","article-title":"Confetti-like depigmentation; a potential sign of rapidly progressing vitiligo","volume":"73","author":"Sosa","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2021.06.003_bib0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2016.10.048","article-title":"New discoveries in the pathogenesis and classification of vitiligo","volume":"77","author":"Rodrigues","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2021.06.003_bib0300","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/archderm.140.6.677","article-title":"Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool","volume":"140","author":"Hamzavi","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2021.06.003_bib0305","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.jid.2015.12.040","article-title":"Development and validation of the vitiligo extent score (VES): an international collaborative initiative","volume":"136","author":"van Geel","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2021.06.003_bib0310","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2133.2012.11197.x","article-title":"Guidelines for the management of vitiligo: the European dermatology forum consensus","volume":"168","author":"Taieb","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2021.06.003_bib0315","first-page":"637","article-title":"Impact of vitiligo on quality of life","volume":"108","author":"Morales-Sanchez","year":"2017","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.annder.2021.06.003_bib0320","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2133.2008.08678.x","article-title":"Identification of categories at risk for high quality of life impairment in patients with vitiligo","volume":"159","author":"Sampogna","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2021.06.003_bib0325","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.jaad.2012.01.038","article-title":"Development and validation of a vitiligo-specific quality-of-life instrument (VitiQol)","volume":"69","author":"Lilly","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2021.06.003_bib0330","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/JID.2015.398","article-title":"The Vitiligo Impact Patient scale (VIPs): development and validation of a vitiligo burden assessment tool","volume":"136","author":"Salzes","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2021.06.003_bib0335","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/bjd.15199","article-title":"Vitiligo and depression: a systematic review and meta-analysis","volume":"177","author":"Lai","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2021.06.003_bib0340","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/1346-8138.12276","article-title":"Impact of genital involvement on the sexual lives of vitiligo patients","volume":"40","author":"Kim Do","year":"2013","journal-title":"J Dermatol"},{"key":"10.1016\/j.annder.2021.06.003_bib0345","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/jamadermatol.2013.927","article-title":"Association between vitiligo extent and distribution and quality-of-life impairment","volume":"149","author":"Silverberg","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.annder.2021.06.003_bib0350","doi-asserted-by":"crossref","first-page":"345","DOI":"10.5021\/ad.2012.24.3.345","article-title":"Pityriasis versicolor on penile shaft in a renal transplant recipient","volume":"24","author":"Ryu","year":"2012","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.annder.2021.06.003_bib0355","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4103\/0378-6323.14001","article-title":"Penile tuberculoid leprosy in a five-year old boy","volume":"71","author":"Kar","year":"2005","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.annder.2021.06.003_bib0360","doi-asserted-by":"crossref","first-page":"519","DOI":"10.4103\/0019-5154.164411","article-title":"Acral vitiligo and lichen sclerosus. Association or a distinct pattern? A clinical and histopathological review of 15 cases","volume":"60","author":"Attili","year":"2015","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.annder.2021.06.003_bib0365","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1046\/j.1365-2133.2000.03635.x","article-title":"Synchronous onset of penile lichen sclerosus and vitiligo","volume":"143","author":"Osborne","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2021.06.003_bib0370","doi-asserted-by":"crossref","first-page":"452","DOI":"10.4103\/0378-6323.29345","article-title":"Condom leukoderma","volume":"72","author":"Banerjee","year":"2006","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.annder.2021.06.003_bib0375","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1034\/j.1600-0560.2001.280208.x","article-title":"Depigmented genital extramammary Paget's disease: a possible histogenetic link to Toker's clear cells and clear cell papulosis","volume":"28","author":"Chen","year":"2001","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.annder.2021.06.003_bib0380","series-title":"Male genital skin disease","first-page":"67","author":"Bunker","year":"2019"},{"key":"10.1016\/j.annder.2021.06.003_bib0385","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/1471-2334-14-329","article-title":"Induction of vitiligo after imiquimod treatment of condylomata acuminata","volume":"14","author":"Li","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.annder.2021.06.003_bib0390","doi-asserted-by":"crossref","first-page":"572","DOI":"10.4103\/0378-6323.182808","article-title":"Vitiligo-like lesions following imiquimod 5% application for condylomata acuminate: an additional case","volume":"82","author":"Maatouk","year":"2016","journal-title":"Indian J Dermatol Leprol"},{"key":"10.1016\/j.annder.2021.06.003_bib0395","first-page":"74","article-title":"Possible mechanisms in the induction of vitiligo-like hypopigmentation by topical imiquimod","volume":"33","author":"Mashiah","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.annder.2021.06.003_bib0400","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1684\/ejd.2018.3449","article-title":"Vitiligo and thyroid disease: a systematic review and meta-analysis","volume":"28","author":"Fan","year":"2018","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.annder.2021.06.003_bib0405","first-page":"CD003263","article-title":"Interventions for vitiligo","volume":"2","author":"Whitton","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.annder.2021.06.003_bib0410","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2310\/7750.2013.12053","article-title":"Low-dose oral mini-pulse dexamethasone therapy in progressive unstable vitiligo","volume":"17","author":"Kanwae","year":"2013","journal-title":"J Cut Med Surg"},{"key":"10.1016\/j.annder.2021.06.003_bib0415","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/j.1365-4632.2007.03282.x","article-title":"Two therapeutic challenges: periocular and genital vitiligo in children successfully treated with pimecrolimus cream","volume":"46","author":"Souza Leite","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.annder.2021.06.003_bib0420","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4103\/2231-4040.197388","article-title":"effectiveness and safety of topical tacrolimus in treatment of vitiligo","volume":"8","author":"Rokni","year":"2017","journal-title":"J Adv Phar Technol Res"},{"key":"10.1016\/j.annder.2021.06.003_bib0425","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jaad.2016.12.041","article-title":"The Vitiligo working group recommendations for narrowband ultraviolet B light phototherapy treatment of vitiligo","volume":"76","author":"Mohammad","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2021.06.003_bib0430","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-4632.2009.03928.x","article-title":"Therapeutic evaluation of UVB-targeted phototherapy in vitiligo that affects less than 10% of the body surface area","volume":"48","author":"Welsh","year":"2009","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.annder.2021.06.003_bib0435","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1468-3083.2006.02101.x","article-title":"Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of 110 patients","volume":"21","author":"Fai","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2021.06.003_bib0440","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1056\/NEJM199004193221601","article-title":"Genital tumours among men with psoriasis exposed to psoralens and ulraviolet. A radiation (PUVA) and ultraviolet B radiation: the photochemotherapy follow-up study","volume":"322","author":"Stern","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2021.06.003_bib0445","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.det.2016.11.007","article-title":"Medical and maintenance treatments for vitiligo","volume":"35","author":"Passeron","year":"2017","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.annder.2021.06.003_bib0450","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/DSS.0000000000000564","article-title":"Special considerations when grafting epithelial sheets in male genital vitiligo","volume":"42","author":"Matsuzaki","year":"2016","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.annder.2021.06.003_bib0455","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/1203475415577752","article-title":"Microskin grafting for stable vitiligo of the penis and vulva: near total pigmentation","volume":"19","author":"Gupta","year":"2015","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.annder.2021.06.003_bib0460","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s13555-014-0050-5","article-title":"Two cases of focal scrotal vitiligo successfully treated by autologous cultured melanocyte transplantation","volume":"4","author":"Li","year":"2014","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.annder.2021.06.003_bib0465","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/jid.2014.527","article-title":"Maintenance therapy of adult vitiligo with 0,1% tacrolimus ointment: a randomized double-blind placebo-controlled study","volume":"135","author":"Cavali\u00e9","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2021.06.003_bib0470","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0140-6736(20)30609-7","article-title":"Ruxolitinib cream for treatment of vitiligo: a randomized, controlled, phase 2 trial","volume":"396","author":"Rosmarin","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.annder.2021.06.003_bib0475","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1038\/jid.2015.335","article-title":"Transcriptional analysis of vitiligo skin reveals the alteration of WNT pathway: a promising target for repigmenting vitiligo patients","volume":"135","author":"Regazzetti","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2021.06.003_bib0480","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0140-6736(20)30747-9","article-title":"First step in a new era for treatment of patients with vitiligo","volume":"396","author":"Passeron","year":"2020","journal-title":"Lancet"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963821000661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963821000661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:10:28Z","timestamp":1758971428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963821000661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0151963821000661"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2021.06.003","relation":{},"ISSN":["0151-9638"],"issn-type":[{"value":"0151-9638","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Male genital vitiligo","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2021.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}